diethylcarbamazine has been researched along with Asymptomatic Conditions in 2 studies
Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Improved treatments for lymphatic filariasis (LF) could accelerate the global elimination program for this disease." | 3.01 | An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia. ( Alfian, R; Bogus, J; Christian, M; Destani, Y; Djuardi, Y; Fischer, PU; Iskandar, E; Lew, D; Lomiga, A; Maylasari, R; Minggu, D; Supali, T; Weil, GJ, 2021) |
| "Human lymphatic filariasis (LF) is a major cause of disability globally." | 1.43 | Circulating filarial antigen detection in brugian filariasis. ( Bhattacharya, SM; Mahajan, RC; Malla, N; Mewara, A; Sehgal, R; Shenoy, RK; Tripathi, PK, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Supali, T | 1 |
| Djuardi, Y | 1 |
| Christian, M | 1 |
| Iskandar, E | 1 |
| Alfian, R | 1 |
| Maylasari, R | 1 |
| Destani, Y | 1 |
| Lomiga, A | 1 |
| Minggu, D | 1 |
| Lew, D | 1 |
| Bogus, J | 1 |
| Weil, GJ | 1 |
| Fischer, PU | 1 |
| Tripathi, PK | 1 |
| Mahajan, RC | 1 |
| Malla, N | 1 |
| Mewara, A | 1 |
| Bhattacharya, SM | 1 |
| Shenoy, RK | 1 |
| Sehgal, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Community Based Safety Study of 2-drug (Diethylcarbamazine and Albendazole) Versus 3-drug (Ivermectin, Diethylcarbamazine and Albendazole) Therapy for Lymphatic Filariasis[NCT02899936] | 23,789 participants (Actual) | Interventional | 2016-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for diethylcarbamazine and Asymptomatic Conditions
| Article | Year |
|---|---|
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antibodies, Protozoan; Asymptomatic Diseases; Brugia; | 2021 |
1 other study available for diethylcarbamazine and Asymptomatic Conditions
| Article | Year |
|---|---|
Circulating filarial antigen detection in brugian filariasis.
Topics: Adult; Animals; Antigens, Helminth; Asymptomatic Diseases; Diethylcarbamazine; Elephantiasis, Filari | 2016 |